AT
Healthcare & Life Sciences
Actym Therapeutics
Actym Therapeutics is a Healthcare & Life Sciences startup, most recent round Series A, 2 tracked investors.
series-a
series-a
Stage
2
Investors
About Actym Therapeutics
Actym Therapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Develops systemic delivery technologies for tumor-specific effects with programmable, combination payload delivery aimed at treating solid tumors.
Explore Actym Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.